Talphera (TLPH) Net Cash Flow (2010 - 2026)
Talphera's (TLPH) quarterly Net Cash Flow came in at -$2.1 million in Q1 2026, up 40.4% year-on-year from -$1.5 million in Q1 2025, and down 184.98% quarter-over-quarter from $2.4 million in Q4 2025.
Talphera (TLPH) Net Cash Flow (2010 - 2026) Analysis & Trends
Talphera's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 40.4% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 76.76% increase from a year earlier, with the FY2025 full-year figure at -$3.0 million, down 194.49% from the prior year.
- Net Cash Flow fell to -$2.1 million in Q1 2026 per TLPH's latest filing, from $2.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $9.2 million in Q1 2022 and bottomed at -$7.7 million in Q4 2023.
- The 5-year median for Net Cash Flow is -$2.1 million (2026), against an average of -$520000.0.
- Across the five-year window, Net Cash Flow soared 518.26% in 2022 and tumbled 401.53% in 2023, its largest moves.
- Year by year, Net Cash Flow stood at $2.5 million in 2022, then tumbled by 401.53% to -$7.7 million in 2023, then surged by 70.61% to -$2.3 million in 2024, then jumped by 208.12% to $2.4 million in 2025, then tumbled by 184.98% to -$2.1 million in 2026.
- Per Business Quant, the three latest TLPH Net Cash Flow figures stand at -$2.1 million (Q1 2026), $2.4 million (Q4 2025), and -$3.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | -2.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.07 Mn |
| Mar 31, 2026 | -2.07 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | -3.33 Mn |
| Sep 30, 2025 | -3.33 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | -3.48 Mn |
| Mar 31, 2025 | -3.48 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Sep 30, 2024 | -2.31 Mn |
| Sep 30, 2024 | -2.31 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Dec 31, 2023 | -7.67 Mn |
| Dec 31, 2023 | -7.67 Mn |